About AMERX
|
|
Amerx Health Care Corporation is a subsidiary of Procyon Corporation, stock symbol PCYN |
Amerx began operations in 1993 and manufactures proprietary wound and skin products, including the Amerigel Skin and Wound Care product line with Oakin®. All manufacturing is done in the United States and complies with rigid cGMP requirements.
Amerigel® products have been reviewed by the FDA (US Food & Drug Administration) and have individual NDC (National Drug Code) assigned to them.
* AmeriGel® Hydrogel Saturated Gauze Dressing
Amerigel® product formulations harness the natural healing power of the Oak tree.
Oakin®, the primary ingredient, has been researched, tested and found to be beneficial to the skin and in the healing process of a variety of wounds. Amerx Health Care continues its research, testing, and development of innovative products. Amerigel® products are available over-the counter and do not require a prescription.
AmeriGel® Wound Dressing was rated the #1 Topical Dressing for Matrixectomies (nail surgery) since 2003 and the #1 Topical Wound/Ulcer Treatment since 2006 by podiatric physicians. (Podiatry Management Annual Survey Edition)
Amerx Health Care is currently seeking approval within the European market (EU), as well as other countries to expand our global presence.
Amerx Health Care is committed to providing high quality products to the medical community and to patients in need of solving wound and skin conditions.
 |
 |
 |
 |
 |
   |
